Is being a Regulatory Affairs Specialist
at risk from AI?

Not in the foreseeable future. While AI will automate document preparation, literature searches, and submission tracking, regulatory affairs fundamentally requires legal accountability and human judgment. Agencies like the FDA require named individuals to sign submissions and take responsibility for compliance decisions. The cost of regulatory errors—product recalls, warning letters, market withdrawal—is too high for companies to delegate final authority to AI. What will change is that specialists will spend less time on administrative tasks and more on strategy, agency negotiations, and cross-functional leadership.

Routine document formatting, deadline tracking, and initial literature reviews are already being automated. AI tools can generate first drafts of common sections in 510(k)s or CTD modules, pull data from clinical study reports, and monitor regulatory databases for changes. Within 2-3 years, expect 60-70% of document preparation time to be AI-assisted. However, the strategic work—choosing regulatory pathways, interpreting ambiguous guidance, negotiating with agencies, and making risk-benefit calls—remains firmly in human hands because it requires accountability, judgment, and relationship capital that AI cannot replicate.

Yes, immediately. Specialists who master AI-assisted workflows will be far more productive and valuable than those who resist. Focus on tools that automate literature review (e.g., AI-powered search and summarization), document generation (templating and drafting assistants), and regulatory intelligence (change-monitoring platforms). The goal is not to be replaced by AI but to use it to eliminate low-value work so you can focus on strategic planning, agency interactions, and cross-functional leadership. Employers will increasingly expect regulatory staff to deliver more with AI leverage.

Junior roles focused on document preparation, data entry, and tracking are at higher risk of compression—companies may need fewer entry-level staff as AI handles routine tasks. However, this also means juniors who quickly develop strategic skills and agency relationship-building will advance faster. Senior specialists with deep regulatory strategy expertise, agency credibility, and cross-functional influence are highly resilient. The career ladder is shifting: you'll need to reach strategic competence faster, but once there, your value is durable. Invest early in building judgment and relationships, not just technical compliance knowledge.

Yes. Highly regulated industries with severe consequences for errors—pharmaceuticals, medical devices, biologics—offer the most resilience because accountability and agency relationships are non-negotiable. Consumer products and less-regulated sectors may see faster AI adoption. Geographically, roles interfacing with the FDA, EMA, or other major agencies are more resilient than purely domestic or emerging-market regulatory roles, because established agencies demand deep procedural knowledge and relationship capital. Specialists working in novel areas (gene therapy, AI-as-a-medical-device, digital health) also have an advantage, as regulatory frameworks are still evolving and require human interpretation.

Unlikely for experienced specialists, but the distribution may shift. Entry-level salaries could stagnate as AI reduces the need for junior staff doing routine document work. However, senior specialists with strategic expertise, agency relationships, and cross-functional leadership skills will remain in high demand, potentially seeing salary growth as their leverage increases. The key is to avoid being pigeonholed as a document preparer. Position yourself as a regulatory strategist who uses AI tools to deliver faster, more informed decisions. Companies will pay a premium for specialists who can navigate complex regulatory landscapes and reduce time-to-market.

Prioritize skills AI cannot replicate: regulatory strategy and pathway selection, agency negotiation and relationship-building, cross-functional stakeholder management, and risk-benefit decision-making under ambiguity. Deepen your expertise in emerging areas like digital health, combination products, or international harmonization where regulatory frameworks are unsettled. Also, become proficient with AI tools for document drafting, literature review, and regulatory intelligence so you can work faster and focus on high-value judgment calls. Finally, develop business acumen—understanding commercial strategy, competitive positioning, and organizational dynamics—so you're seen as a strategic partner, not just a compliance gatekeeper.